ARC Medical is a clinical stage company that is preventing surgical adhesions to improve patient recovery. ARC has the only liquid medical devices that flow and form a temporary physical barrier film that prevents the formation of adhesions throughout the entire surgical area. ARC's medical devices have proven efficacious and easy to apply and can be used in a multiple surgical indications. ARC's products are backed by: - Favorable JOCOAT™ orthopedic surgical patient data (N=4); - Positive IPCOAT™ gynecological and abdominal safety clinical trial data (N=76); and - Superior IPCOAT™ head-to-head preclinical efficacy compared with 3 key competitors. ARC has received serious expressions of interest from multiple large Japanese medical devices companies and anticipates closing a deal for Japan prior to the end of 2024. In parallel, ARC is seeking to raise $15+ million to fund US development.